DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Upadhyay VA, Brunner AM, Fathi AT.
Isocitrate dehydrogenase (IDH) inhibition as treatment of myeloid malignancies: progress and future directions.
Pharmacol Ther 2017;
177 (17) 123-128
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.